Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C16H24N2 · HCl
CAS Number:
Molecular Weight:
280.84
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
41116107
EC Number:
214-936-4
MDL number:
grade
analytical standard
Quality Level
assay
≥98.0% (HPLC)
shelf life
limited shelf life, expiry date on the label
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
impurities
≤1.0% water
application(s)
forensics and toxicology
veterinary
format
neat
SMILES string
CC1=CC(C(C)(C)C)=CC(C)=C1CC2=NCCN2.Cl
InChI
1S/C16H24N2.ClH/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15;/h8-9H,6-7,10H2,1-5H3,(H,17,18);1H
InChI key
YGWFCQYETHJKNX-UHFFFAOYSA-N
General description
Xylometazoline hydrochloride is a derivative of imidazole, and a representative of the class of α1 agonists. It is commonly used in nasal decongestants, which works on the principle of constricting the blood vessels in the mucous membranes.
Application
Xylometazoline hydrochloride may be used as a reference standard in determining the xylometazoline hydrochloride content in samples of nasal drops using high performance liquid chromatography (HPLC).
Biochem/physiol Actions
α-adrenoceptor agonist; imidazoline binding site ligand.
Still not finding the right product?
Explore all of our products under Xylometazoline hydrochloride
signalword
Danger
hcodes
pcodes
Hazard Classifications
Acute Tox. 3 Oral
Storage Class
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
High-performance liquid chromatographic method for the assay of dexamethasone and xylometazoline in nasal drops containing methyl p-hydroxybenzoate.
Milojevic Z, et al.
Journal of Chromatography A, 949(1-2), 79-82 (2002)
Pharmaceutical Chemistry E-Book (2011)
Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study.
FC and GM
Drugs Under Experimental and Clinical Research, 28(1), 27-35 (2002)
